Login / Signup

A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis.

Himanshu DeshwalSubha GhoshKaren MagruderJohn R BartholomewJennifer MontgomeryAtul C Mehta
Published in: Vascular medicine (London, England) (2019)
Fibrosing mediastinitis (FM) is a rare disorder of inflammation and fibrosis involving the mediastinum. The formation of fibroinflammatory mass in the mediastinum can lead to obstruction of mediastinal structures and cause severe debilitating and life-threatening symptoms. Superior vena cava syndrome (SVCS) is a dreaded complication of FM with no medical therapy proven to be efficacious. Spiral vein grafting has long been utilized as first-line therapy for SVC syndrome due to FM. Endovascular repair with stents and angioplasty for malignant causes of SVC syndrome is well established. However, there are limited data on their utility in SVC syndrome due to FM. We present two cases of SVC syndrome due to FM treated with endovascular stenting and a detailed review of current literature on its utility in SVCS due to benign causes.
Keyphrases
  • vena cava
  • case report
  • healthcare
  • systematic review
  • oxidative stress
  • lymph node
  • high resolution
  • coronary artery disease
  • big data
  • atrial fibrillation
  • newly diagnosed
  • percutaneous coronary intervention